Output:
Factor(up_probability=0.3, 
reason=The financial indicators show mixed signals. While total revenue for Q2 2024 (80,117,000) increased significantly to Q3 2024 (92,489,000), the EBITDA and net income dropped markedly from Q2 (8,307,000 and 6,358,000 respectively) to Q3 (4,642,000 and 466,000), indicating some deterioration in profitability. The negative performance in key metrics signals potential investor concern that could overshadow the revenue increase. Additionally, upcoming regulatory scrutiny due to the FTC lawsuit adds uncertainty and potential regulatory risk. Together, these elements suggest a higher likelihood of downside pressure on the stock, representing a 30% chance of an immediate price increase.)